Prostate Cancer

Decipher Genomic Classifier Augments Progression Surveillance for Patients With Prostate Cancer
The addition of a novel genomic classifier (GC) during active surveillance for prostate cancer (PCa) was shown to predict disease progression independently from clinical risk assessment tools such as multiparametric magnetic resonance imaging (mpMRI), according to a recent study presented at the Society of Urologic Oncology (SUO) 25th Annual Meeting. ...
Advertisement

Latest News

Advertisement

Prostate Cancer Knowledge Hubs

Curated clinical content on prostate cancer types, therapies, and technologies

Localized
Localized

Conference Coverage

Advertisement
Advertisement
Latest News